These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. Endothelial dysfunction and its role in diabetic vascular disease. Hartge MM; Kintscher U; Unger T Endocrinol Metab Clin North Am; 2006 Sep; 35(3):551-60, viii-ix. PubMed ID: 16959585 [TBL] [Abstract][Full Text] [Related]
54. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes. Tooke JE J Diabetes Complications; 2000; 14(4):197-200. PubMed ID: 11004428 [TBL] [Abstract][Full Text] [Related]
55. [Endothelial dysfunction and plaque inflammation in diabetic macroangiopathy]. Ikura Y; Kitabayashi C; Ueda M Nihon Rinsho; 2006 Nov; 64(11):1980-3. PubMed ID: 17087286 [No Abstract] [Full Text] [Related]
56. [Physical activity and endothelial dysfunction in type 2 diabetic patients: the role of nitric oxide and oxidative stress]. Brinkmann C; Schwinger RH; Brixius K Wien Med Wochenschr; 2011 Jun; 161(11-12):305-14. PubMed ID: 21360292 [TBL] [Abstract][Full Text] [Related]
57. [Therapeutic targets in diabetic vasculopathy]. Sánchez Ferrer CF An R Acad Nac Med (Madr); 2003; 120(4):659-69; discussion 669-74. PubMed ID: 15147053 [TBL] [Abstract][Full Text] [Related]
58. The atherosclerotic process and its exacerbation by diabetes. Baumgartl HJ; Standl E Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S487-92. PubMed ID: 11460593 [TBL] [Abstract][Full Text] [Related]
59. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Pacher P; Obrosova IG; Mabley JG; Szabó C Curr Med Chem; 2005; 12(3):267-75. PubMed ID: 15723618 [TBL] [Abstract][Full Text] [Related]
60. The physiology and pathophysiology of the nitric oxide/superoxide system. Münzel T; Heitzer T; Harrison DG Herz; 1997 Jun; 22(3):158-72. PubMed ID: 9232165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]